MarketsNotableConfirmed
9.4
Johnson & Johnson raises FY2026 guidance following Q2 earnings beat
Valor Econômico·US·2 days ago
MarketsSingle-sourceLow
2.1
Johnson & Johnson reports Q2 2026 adjusted EPS of $2.90
Johnson & Johnson reported second-quarter 2026 adjusted earnings per share of $2.90, aligning with market expectations. The result indicates stable performance for the healthcare conglomerate, with no significant deviation from analyst consensus.
Score Breakdown
Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3
Related signals
8 foundHealthNotableConfirmedDeveloping
10.0
International field hospitals address critical gaps in Venezuelan public healthcare
El Nacional·VE·3 days ago
HealthNotableConfirmedDeveloping
10.0
Venezuelan population utilizes foreign humanitarian medical missions for chronic care
ClarínLO·VE·1 day ago
HealthNotableCorroborating
10.0
Regulatory oversight failures in Bosnia and Herzegovina private healthcare sector
Balkan InsightLO·BA·3 days ago
MarketsNotableConfirmedDeveloping
10.0
Netflix shares decline in after-hours trading following Q2 revenue report
AftenpostenLO·US·about 19 hours ago
MarketsNotableConfirmedDeveloping
10.0
Upcoming Q2 earnings reports for SEB and ASML
Dagens IndustriLO·SE · NL·3 days ago
MarketsNotableConfirmedDeveloping
10.0
Netflix faces earnings volatility following significant market capitalization decline
Irish IndependentLO·US·about 19 hours ago
MarketsNotableConfirmedDeveloping
10.0
China's state-owned airlines project increased H1 losses citing elevated fuel costs
Nikkei Asia·CN·3 days ago